A detailed history of Zions Bancorporation, N.A. transactions in Moderna, Inc. stock. As of the latest transaction made, Zions Bancorporation, N.A. holds 144 shares of MRNA stock, worth $9,468. This represents 0.0% of its overall portfolio holdings.

Number of Shares
144
Previous 153 5.88%
Holding current value
$9,468
Previous $16,000 6.25%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$101.21 - $166.61 $910 - $1,499
-9 Reduced 5.88%
144 $17,000
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $4,353 - $5,887
51 Added 50.0%
153 $16,000
Q4 2023

Feb 12, 2024

SELL
$69.51 - $104.43 $7,437 - $11,174
-107 Reduced 51.2%
102 $10,000
Q3 2023

Nov 07, 2023

SELL
$96.41 - $126.61 $96 - $126
-1 Reduced 0.48%
209 $21,000
Q2 2023

Jul 28, 2023

SELL
$118.5 - $160.53 $3,436 - $4,655
-29 Reduced 12.13%
210 $25,000
Q1 2023

May 10, 2023

SELL
$135.66 - $197.02 $5,562 - $8,077
-41 Reduced 14.64%
239 $36,000
Q4 2022

Feb 10, 2023

BUY
$118.38 - $210.04 $8,168 - $14,492
69 Added 32.7%
280 $50,000
Q3 2022

Nov 08, 2022

BUY
$118.07 - $194.18 $1,298 - $2,135
11 Added 5.5%
211 $25,000
Q2 2022

Aug 05, 2022

SELL
$117.13 - $176.59 $8,784 - $13,244
-75 Reduced 27.27%
200 $29,000
Q1 2022

May 13, 2022

BUY
$126.46 - $235.05 $1,770 - $3,290
14 Added 5.36%
275 $47,000
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $12,420 - $20,268
55 Added 26.7%
261 $66,000
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $10,651 - $23,254
48 Added 30.38%
206 $79,000
Q2 2021

Aug 11, 2021

BUY
$129.91 - $234.98 $2,078 - $3,759
16 Added 11.27%
158 $37,000
Q1 2021

May 13, 2021

SELL
$109.18 - $185.98 $4,148 - $7,067
-38 Reduced 21.11%
142 $19,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $5,522 - $14,268
84 Added 87.5%
180 $19,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $1,521 - $2,655
28 Added 41.18%
96 $7,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $2,017 - $5,440
68 New
68 $4,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Zions Bancorporation, N.A. Portfolio

Follow Zions Bancorporation, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Zions Bancorporation, N.A. with notifications on news.